Nanalysis Scientific Corp.
NSCIF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 59.8% | 14.7% | 54.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28% | 13.9% | 42.2% | 63.8% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -16.8% | -31.1% | -21.2% | 8.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -29.9% | -59% | -39.9% | -11% |
| EPS Diluted | -0.12 | -0.16 | -0.11 | -0.033 |
| % Growth | 25% | -45.5% | -229.3% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |